Literature DB >> 31954089

Insights for clinical diagnostic indicators of virus and host in chronic hepatitis B infection.

Qishui Ou1,2,3, Jianhui Guo1,2,3, Yongbin Zeng1,2,3, Huijuan Chen1,2,3.   

Abstract

Covalently closed circular DNA (cccDNA), which is stably present in the nucleus of hepatocytes, is an important indicator for evaluating antiviral efficacy. Since cccDNA quantification requires an invasive procedure, serum biological markers that can effectively reflect the transcriptional activity of intrahepatic virus and the efficacy of treatment are required. Here, from the aspects of virus and host, we outline the focus of clinical research of HBV in recent years, including HBV RNA, empty virus, hepatitis B core-related antigen and changes in the immune response. We briefly discuss their significance in predicting disease activity and monitoring treatment response in chronic hepatitis B. On this basis, some issues worthy of attention in laboratory diagnosis are proposed.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  HBV RNA; chronic hepatitis B; covalently closed circular DNA; empty virus; laboratory diagnosis

Mesh:

Substances:

Year:  2020        PMID: 31954089     DOI: 10.1111/jvh.13260

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  6 in total

1.  Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy.

Authors:  Claudia Hawkins; Minhee Kang; Debika Bhattacharya; Gavin Cloherty; Mary Kuhns; Roy Matining; Chloe Thio; Wadzanai Samaneka; Lameck Chinula; Nyirenda Mulinda; Sharlaa Badal-Faesen; Patcharaphan Sugandhavesa; Javier Lama; Simani Gaseitsiwe; Vera Holzmayer; Mark Anderson; Robert Murphy; Marion Peters
Journal:  AIDS       Date:  2022-02-14       Impact factor: 4.632

2.  Long Noncoding RNA TFAP2A-AS1 Suppressed Hepatitis B Virus Replication by Modulating miR-933/HDAC11.

Authors:  Yu Cheng; Weiwu Shi; Xudong Cui; Lei Sun; Yi Nan; Hong Yao; Jian Fan; LiYing Zhu; Lei Yu
Journal:  Dis Markers       Date:  2022-04-18       Impact factor: 3.464

3.  Proteomic characterization of the natural history of chronic HBV infection revealed by tandem mass tag-based quantitative proteomics approach.

Authors:  Zhen Xun; Xiaobao Yao; Chenggong Zhu; Yuchen Ye; Songhang Wu; Tianbin Chen; Yongbin Zeng; Caorui Lin; Bin Yang; Qishui Ou; Can Liu
Journal:  Mater Today Bio       Date:  2022-05-25

4.  Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV.

Authors:  Chih-Wei Tseng; Wen-Chun Liu; Chi-Yi Chen; Ting-Tsung Chang; Kuo-Chih Tseng
Journal:  BMC Infect Dis       Date:  2022-04-09       Impact factor: 3.090

5.  The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients.

Authors:  Chih-Wei Tseng; Wen-Chun Liu; Ping-Hung Ko; Yen-Chun Chen; Kuo-Chih Tseng; Ting-Tsung Chang
Journal:  Viruses       Date:  2022-08-18       Impact factor: 5.818

Review 6.  Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management.

Authors:  Alicia Vachon; Carla Osiowy
Journal:  Viruses       Date:  2021-05-21       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.